Piper Thomas, Thevis Mario
Center for Preventive Doping Research-Institute of Biochemistry, German Sport University Cologne, Köln, Germany.
European Monitoring Center for Emerging Doping Agents (EuMoCEDA), Cologne/Bonn, Germany.
Drug Test Anal. 2025 Jul;17(7):944-953. doi: 10.1002/dta.3793. Epub 2024 Sep 16.
The determination of serum concentrations of testosterone (T) and 4-androstenedione (A4) was implemented into the steroidal module of the Athlete Biological Passport in 2023. Monitoring T, A4, and the ratio of T/A4 in a longitudinal manner enables the detection of the misuse of low-dose T administrations especially in female athletes, whereas urinary markers of the steroid profile may not be influenced significantly. In contrast to the urinary steroid profile, knowledge on confounding factors regarding serum concentrations of T and A4 is yet comparably scarce, and corroborating exogenous sources of the target analytes by isotope ratio mass spectrometry (IRMS) is desirable. In a recent study, it was demonstrated that carbon isotope ratios (CIRs) of serum steroids can be determined if analyte concentrations permit. The therein-employed method utilized 2D-GC/IRMS, and only a limited number of potential endogenous reference compounds were available. The here-presented approach uses complementary analyte purification strategies, addressing previous limitations. A high-performance liquid chromatography cleanup was developed and fully validated for serum steroids in order to enable all doping control laboratories to potentially implement this method alongside existing protocols for urinary steroids. Besides the already-investigated endogenous steroids cholesterol, dehydroepiandrosterone sulfate, androsterone sulfate, and epiandrosterone sulfate, two additional steroids were included in the test menu, namely, pregnenolone sulfate and 5-androstene-3β,17β-diol sulfate. Serum steroid concentrations down to 25 ng/mL were found to allow robust CIR determinations, and a reference population encompassing 124 male and female athlete samples was investigated to enable the calculation of population-based thresholds for all relevant steroid combinations.
睾酮(T)和4-雄烯二酮(A4)血清浓度的测定于2023年被纳入运动员生物护照的甾体模块。纵向监测T、A4以及T/A4比值能够检测出低剂量T给药的滥用情况,尤其是在女性运动员中,而甾体谱的尿液标志物可能不会受到显著影响。与尿液甾体谱不同,关于T和A4血清浓度的混杂因素的知识仍然相对较少,因此通过同位素比值质谱法(IRMS)确证目标分析物的外源性来源是很有必要的。在最近的一项研究中,已证明如果分析物浓度允许,血清甾体的碳同位素比值(CIRs)是可以测定的。该研究中使用的方法采用二维气相色谱/同位素比值质谱联用(2D-GC/IRMS),并且只有有限数量的潜在内源性参考化合物可用。本文提出的方法采用了互补的分析物纯化策略,解决了先前的局限性。为血清甾体开发了一种高效液相色谱净化方法并进行了全面验证,以便所有兴奋剂检测实验室都有可能将该方法与现有的尿液甾体检测方案一起实施。除了已经研究过的内源性甾体胆固醇、硫酸脱氢表雄酮、硫酸雄酮和硫酸表雄酮外,测试菜单中还包括另外两种甾体,即硫酸孕烯醇酮和硫酸5-雄烯-3β,17β-二醇。发现低至25 ng/mL的血清甾体浓度也能进行可靠的CIR测定,并且对包含124份男性和女性运动员样本的参考人群进行了研究,以便计算所有相关甾体组合基于人群的阈值。